Brief: Acura Pharmaceuticals Q1 Loss Per Share $0.04
01/10/2019 12:17
Oct 1 (Reuters) - Acura Pharmaceuticals Inc ACUR.PK :
* ACURA PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2019
FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.04
* AS OF SEPTEMBER 27, 2019, COMPANY HAD CASH OF $0.6 MILLION
* CASH & MONTHLY LICENSE PAYMENTS FROM AD PHARMA WILL FUND
OPERATIONS THROUGH 2020
Source text for Eikon: ID:nGNX21KC01
Further company coverage: ACUR.PK
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way